|
1
|
Smolen JS, Aletaha D and McInnes IB:
Rheumatoid arthritis. Lancet. 388:2023–2038. 2016.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Scott DL, Wolfe F and Huizinga TW:
Rheumatoid arthritis. Lancet. 376:1094–1108. 2010.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Davis JM 3rd: Rheumatoid arthritis: A
severe disease that preventive approaches would greatly benefit.
Clin Ther. 41:1240–1245. 2019.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Derksen VFAM, Huizinga TWJ and van der
Woude D: The role of autoantibodies in the pathophysiology of
rheumatoid arthritis. Semin Immunopathol. 39:437–446.
2017.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Alam J, Jantan I and Bukhari SNA:
Rheumatoid arthritis: Recent advances on its etiology, role of
cytokines and pharmacotherapy. Biomed Pharmacother. 92:615–633.
2017.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Goldfeder RL, Wall DP, Khoury MJ,
Ioannidis JPA and Ashley EA: Human genome sequencing at the
population scale: A primer on high-throughput DNA sequencing and
analysis. Am J Epidemiol. 186:1000–1009. 2017.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Ma Y, Shi N, Li M, Chen F and Niu H:
Applications of next-generation sequencing in systemic autoimmune
diseases. Genomics Proteomics Bioinformatics. 13:242–249.
2015.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Yuan M, Wang S, Yu L, Qu B, Xu L, Liu L,
Sun H, Li C, Shi Y and Liu H: Long noncoding RNA profiling revealed
differentially expressed lncRNAs associated with disease activity
in PBMCs from patients with rheumatoid arthritis. PLoS One.
12(e0186795)2017.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Ye H, Wang X, Wang L, Chu X, Hu X, Sun L,
Jiang M, Wang H, Wang Z, Zhao H, et al: Full high-throughput
sequencing analysis of differences in expression profiles of long
noncoding RNAs and their mechanisms of action in systemic lupus
erythematosus. Arthritis Res Ther. 21(70)2019.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Wang J, Peng H, Tian J, Ma J, Tang X, Rui
K, Tian X, Wang Y, Chen J, Lu L, et al: Upregulation of long
noncoding RNA TMEVPG1 enhances T helper type 1 cell response in
patients with Sjögren syndrome. Immunol Res. 64:489–496.
2016.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Dolcino M, Tinazzi E, Puccetti A and
Lunardi C: In systemic sclerosis, a unique long non coding RNA
regulates genes and pathways involved in the three main features of
the disease (Vasculopathy, Fibrosis and Autoimmunity) and in
carcinogenesis. J Clin Med. 8(E320)2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Peng QL, Zhang YM, Yang HB, Shu XM, Lu X
and Wang GC: Transcriptomic profiling of long non-coding RNAs in
dermatomyositis by microarray analysis. Sci Rep.
6(32818)2016.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Mattick JS: The state of long non-coding
RNA biology. Noncoding RNA. 4(E17)2018.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Panzeri I, Rossetti G, Abrignani S and
Pagani M: Long intergenic non-coding RNAs: Novel drivers of human
lymphocyte differentiation. Front Immunol. 6(175)2015.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Pagani M, Rossetti G, Panzeri I, de Candia
P, Bonnal RJ, Rossi RL, Geginat J and Abrignani S: Role of
microRNAs and long-non-coding RNAs in CD4(+) T-cell
differentiation. Immunol Rev. 253:82–96. 2013.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Kondo Y, Yokosawa M, Kaneko S, Furuyama K,
Segawa S, Tsuboi H, Matsumoto I and Sumida T: Review:
Transcriptional regulation of CD4+ T cell differentiation in
experimentally induced arthritis and rheumatoid arthritis.
Arthritis Rheumatol. 70:653–661. 2018.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Arnett FC, Edworthy SM, Bloch DA, McShane
DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH and Luthra
HS: The American rheumatism association 1987 revised criteria for
the classification of rheumatoid arthritis. Arthritis Rheum.
31:315–324. 1988.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Jou JM, Lewis SM, Briggs C, Lee SH, De La
Salle B and McFadden S: International Council for Standardization
in Haematology. ICSH review of the measurement of the erythocyte
sedimentation rate. Int J Lab Hematol. 33:125–132. 2011.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Ailus K, Melamies L, Tuomi T, Palosuo T
and Aho K: Measuring rheumatoid factor in nonrheumatoid subjects:
Immunoturbidimetric assay, latex slide test, and enzyme-linked
immunosorbent assay compared. Clin Chem. 37:1766–1769.
1991.PubMed/NCBI
|
|
20
|
Moutachakkir M, Lamrani Hanchi A, Baraou
A, Boukhira A and Chellak S: Immunoanalytical characteristics of
C-reactive protein and high sensitivity C-reactive protein. Ann
Biol Clin (Paris). 75:225–229. 2017.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Shen R, Ren X, Jing R, Shen X, Chen J, Ju
S and Yang C: Rheumatoid factor, anti-cyclic citrullinated peptide
antibody, C-reactive protein, and erythrocyte sedimentation rate
for the clinical diagnosis of rheumatoid arthritis. Lab Med.
46:226–229. 2015.PubMed/NCBI View Article : Google Scholar
|
|
22
|
McWilliams DF, Kiely PDW, Young A,
Joharatnam N, Wilson D and Walsh DA: Interpretation of DAS28 and
its components in the assessment of inflammatory and
non-inflammatory aspects of rheumatoid arthritis. BMC Rheumatol.
2(8)2018.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Paradowska A, Maślińiski W,
Grzybowska-Kowalczyk A and Łacki J: The function of interleukin 17
in the pathogenesis of rheumatoid arthritis. Arch Immunol Ther Exp
(Warsz). 55:329–334. 2007.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Astry B, Venkatesha SH and Moudgil KD:
Involvement of the IL-23/IL-17 axis and the Th17/Treg balance in
the pathogenesis and control of autoimmune arthritis. Cytokine.
74:54–61. 2015.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Sparks JA: Rheumatoid arthritis. Ann
Intern Med. 170:ITC1–ITC16. 2019.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Okroj M, Heinegård D, Holmdahl R and Blom
AM: Rheumatoid arthritis and the complement system. Ann Med.
39:517–530. 2007.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Guttman M and Rinn JL: Modular regulatory
principles of large non-coding RNAs. Nature. 482:339–346.
2012.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Hur K, Kim SH and Kim JM: Potential
implications of long noncoding RNAs in autoimmune diseases. Immune
Netw. 19(e4)2019.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Choy E: Understanding the dynamics:
Pathways involved in the pathogenesis of rheumatoid arthritis.
Rheumatology (Oxford). 51 (Suppl 5):v3–v11. 2012.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Luo Q, Xu C, Li X, Zeng L, Ye J, Guo Y,
Huang Z and Li J: Comprehensive analysis of long non-coding RNA and
mRNA expression profiles in rheumatoid arthritis. Exp Ther Med.
14:5965–5973. 2017.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Liu H, Yao S, Dann SM, Qin H, Elson CO and
Cong Y: ERK differentially regulates Th17- and Treg-cell
development and contributes to the pathogenesis of colitis. Eur J
Immunol. 43:1716–1726. 2013.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Zhang Y, Zhang Y, Gu W and Sun B: TH1/TH2
cell differentiation and molecular signals. Adv Exp Med Biol.
841:15–44. 2014.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Jiang D, Lenardo MJ and Zúñiga-Pflücker
JC: p53 prevents maturation to the CD4+CD8+ stage of thymocyte
differentiation in the absence of T cell receptor rearrangement. J
Exp Med. 183:1923–1928. 1996.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Zhang H, Xu CF, Ren C, Wu TT, Dong N and
Yao YM: Novel role of p53 in septic immunosuppression: Involvement
in loss and dysfunction of CD4+ T lymphocytes. Cell Physiol
Biochem. 51:452–469. 2018.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Asquith DL, Bryce SA and Nibbs RJ:
Targeting cell migration in rheumatoid arthritis. Curr Opin
Rheumatol. 27:204–211. 2015.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Hähnlein JS, Nadafi R, de Jong T,
Ramwadhdoebe TH, Semmelink JF, Maijer KI, Zijlstra IA, Maas M,
Gerlag DM, Geijtenbeek TBH, et al: Impaired lymph node stromal cell
function during the earliest phases of rheumatoid arthritis.
Arthritis Res Ther. 20(35)2018.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Radstake TR, van der Voort R, ten
Brummelhuis M, de Waal Malefijt M, Looman M, Figdor CG, van den
Berg WB, Barrera P and Adema GJ: Increased expression of CCL18,
CCL19, and CCL17 by dendritic cells from patients with rheumatoid
arthritis, and regulation by Fc gamma receptors. Ann Rheum Dis.
64:359–367. 2005.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Förster R, Davalos-Misslitz AC and Rot A:
CCR7 and its ligands: Balancing immunity and tolerance. Nat Rev
Immunol. 8:362–371. 2008.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Hauser MA and Legler DF: Common and biased
signaling pathways of the chemokine receptor CCR7 elicited by its
ligands CCL19 and CCL21 in leukocytes. J Leukoc Biol. 99:869–882.
2016.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Hu Z, Li Y, Van Nieuwenhuijze A, Selden
HJ, Jarrett AM, Sorace AG, Yankeelov TE, Liston A and Ehrlich LIR:
CCR7 modulates the generation of thymic regulatory T cells by
altering the composition of the thymic dendritic cell compartment.
Cell Rep. 21:168–180. 2017.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Shi LJ, Li JH, Cen XM, Yang NP, Yin G and
Xie QB: CCL19/IL-1beta positive feedback loop involved in the
progress of inflammation in rheumatoid arthritis. Sichuan Da Xue
Xue Bao Yi Xue Ban. 46:272–275. 2015.PubMed/NCBI(In Chinese).
|
|
43
|
Viereck J and Thum T: Circulating
noncoding RNAs as biomarkers of cardiovascular disease and injury.
Circ Res. 120:381–399. 2017.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Dang X, Lian L and Wu D: The diagnostic
value and pathogenetic role of lncRNA-ATB in patients with
osteoarthritis. Cell Mol Biol Lett. 23(55)2018.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Fan CN, Ma L and Liu N: Systematic
analysis of lncRNA-miRNA-mRNA competing endogenous RNA network
identifies four-lncRNA signature as a prognostic biomarker for
breast cancer. J Transl Med. 16(264)2018.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Knoll M, Lodish HF and Sun L: Long
non-coding RNAs as regulators of the endocrine system. Nat Rev
Endocrinol. 11:151–160. 2015.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Quinn JJ and Chang HY: Unique features of
long non-coding RNA biogenesis and function. Nat Rev Genet.
17:47–62. 2016.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Zhang Y, Xu YZ, Sun N, Liu JH, Chen FF,
Guan XL, Li A, Wang F, Zhao QF, Wang HY, et al: Long noncoding RNA
expression profile in fibroblast-like synoviocytes from patients
with rheumatoid arthritis. Arthritis Res Ther.
18(227)2016.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Linden A: Measuring diagnostic and
predictive accuracy in disease management: An introduction to
receiver operating characteristic (ROC) analysis. J Eval Clin
Pract. 12:132–139. 2006.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Cook NR: Statistical evaluation of
prognostic versus diagnostic models: Beyond the ROC curve. Clin
Chem. 54:17–23. 2008.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Nishimura K, Sugiyama D, Kogata Y, Tsuji
G, Nakazawa T, Kawano S, Saigo K, Morinobu A, Koshiba M, Kuntz KM,
et al: Meta-analysis: Diagnostic accuracy of anti-cyclic
citrullinated peptide antibody and rheumatoid factor for rheumatoid
arthritis. Ann Intern Med. 146:797–808. 2007.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Anderson JK, Zimmerman L, Caplan L and
Michaud K: Measures of rheumatoid arthritis disease activity:
Patient (PtGA) and provider (PrGA) global assessment of disease
activity, disease activity score (DAS) and disease activity score
with 28-joint counts (DAS28), simplified disease activity index
(SDAI), clinical disease activity index (CDAI), patient activity
score (PAS) and patient activity score-II (PASII), routine
assessment of patient index data (RAPID), rheumatoid arthritis
disease activity index (RADAI) and rheumatoid arthritis disease
activity index-5 (RADAI-5), chronic arthritis systemic index
(CASI), patient-based disease activity score with ESR (PDAS1) and
patient-based disease activity score without ESR (PDAS2), and mean
overall index for rheumatoid arthritis (MOI-RA). Arthritis Care Res
(Hoboken). 63 (Suppl 11):S14–S36. 2011.PubMed/NCBI View Article : Google Scholar
|
|
53
|
van Riel PL and Renskers L: The disease
activity score (DAS) and the disease activity score using 28 joint
counts (DAS28) in the management of rheumatoid arthritis. Clin Exp
Rheumatol. 34 (5 Suppl 101):S40–S44. 2016.PubMed/NCBI
|
